TrialJournal of Alzheimer's disease : JAD2020

Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.

Gary E Gibson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.